Top Section/Ad
Top Section/Ad
Most recent
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
Pair enjoyed strong execution and tight pricing as US high grade credit remained resilient in the face of a sell-off in equity markets
More articles/Ad
More articles/Ad
More articles
-
Government interventions staved off pandemic-related defaults, though macro headwinds are causing uncertainty -
Verona Pharma and Borr Drilling raise capital at opportune moment
-
Finances drug company's buyout by Carlyle and PAI Partners
-
UK blocks have been few and far between in recent months
-
GSK’s consumer health business trades down on London debut
-
Vaccine financier marketing trade amid major disruption in UK politics
